… Thus, we conclude that in almost all patients with atrial fibrillation, the risk of ischemic stroke
… anticoagulant treatment and that most atrial fibrillation patients should be offered effective …

Objective: To examine the relationship between international normalized ratio (INR) and
outcomes (major bleeding events and strokes) in patients with atrial fibrillation (AF) receiving …

… eligible patients, we determined the diagnosis of atrial fibrillation by … warfarin among
patients from the community, only patients with an established diagnosis of atrial fibrillation …

… Conclusions: We were able to determine the MCID of warfarin therapy for the prevention
of stroke from the perspective of patients with nonvalvular atrial fibrillation. Their MCIDs were …

… edoxaban with warfarin in 21,105 patients with moderate-to-high-risk atrial fibrillation (median …
with warfarin in patients with atrial fibrillation who were at moderate-to-high risk for stroke. …

… safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known.
… of edoxaban with warfarin in 21,105 patients with moderate-to-high-risk atrial fibrillation (…

… In conclusion, we compared two doses of dabigatran with warfarin in patients who had atrial
fibrillation and who were at risk for stroke. As compared with warfarin, the 110-mg dose of …

… Events in Atrial Fibrillation (ARISTOTLE) trial, 7 we compared apixaban with warfarin for
the prevention of stroke or systemic embolism in patients with atrial fibrillation and at least one …

… with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe.
… Atrial fibrillation is the indication for warfarin therapy in approximately 64% of the patients in …

… The BAFTA study [5] assessed the role of anticoagulation compared to aspirin alone in
elderly patients with atrial fibrillation, and showed how warfarin halved the risk of stroke with a …